Compare ProShares Ultra Gold ETF (UGL) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ProShares Ultra Gold ETF vs GeneDx Holdings Corp — how do they compare? ProShares Ultra Gold ETF trades at $44.93, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). Which is the better fit depends on your goals.
| UGL | WGS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $85.62 | $167.51 |
52-Week Low | $33.59 | $34.51 |
Market Cap | — | $1.80B |
Enterprise Value | — | $1.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ProShares Ultra Gold ETF
UGL is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Bloomberg Gold Subindex. It is a tactical tool designed for sophisticated investors to magnify short-term bullish views on gold prices through the use of futures and swap contracts, rather than holding physical bullion.
Read more on UGL →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
